v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Total
Convertible Preferred Stock
Total Figure Technology Solutions, Inc. Stockholders' Equity
Convertible Preferred Stock
Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interests in Consolidated Subsidiaries
Preferred Stock, Beginning balance (in shares) at Dec. 31, 2022       104,575,110        
Beginning balance at Dec. 31, 2022 $ 260,219,000   $ 250,719,000 $ 1,000 $ 1,000 $ 540,540,000 $ (289,823,000) $ 9,500,000
Common stock, Beginning balance (in shares) at Dec. 31, 2022         51,035,303      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of stock options and warrants (in shares)         582,905      
Exercise of stock options and warrants 1,143,000   1,143,000     1,143,000    
Stock compensation expense 13,450,000   13,450,000     13,450,000    
Dilution 54,000   (307,000)       (307,000) 361,000
Net income (loss) $ (52,443,000)   (47,935,000)       (47,935,000) (4,508,000)
Preferred Stock, Ending balance (in shares) at Dec. 31, 2023 104,575,110 104,575,110   104,575,110        
Ending balance at Dec. 31, 2023 $ 222,423,000   217,070,000 $ 1,000 $ 1,000 555,133,000 (338,065,000) 5,353,000
Common stock, Ending balance (in shares) at Dec. 31, 2023 51,618,208       51,618,208      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance and exchange of equity (in shares)         16,498,104      
Issuance and exchange of equity $ 1,000   1,000   $ 1,000      
Issuance of preferred stock warrants 6,977,000   6,977,000     6,977,000    
Exercise of stock options and warrants (in shares)         545,555      
Exercise of stock options and warrants 867,000   867,000     867,000    
Stock compensation expense 34,526,000   34,526,000     34,526,000    
Noncontrolling interest investment in subsidiary 290,000             290,000
Dividends & redemptions of subsidiaries (1,312,000)   (1,265,000)     (1,265,000)   (47,000)
Issuance of Series E preferred stock, net of issuance costs (in shares)       7,325,385        
Issuance of Series E preferred stock, net of issuance costs 71,774,000   71,774,000 $ 1,000   71,773,000    
Net income (loss) 14,026,000   11,738,000       11,738,000 2,288,000
Preferred Stock, Ending balance (in shares) at Sep. 30, 2024       111,900,495        
Ending balance at Sep. 30, 2024 $ 349,572,000   341,688,000 $ 2,000 $ 2,000 668,011,000 (326,327,000) 7,884,000
Common stock, Ending balance (in shares) at Sep. 30, 2024         68,661,867      
Preferred Stock, Beginning balance (in shares) at Dec. 31, 2023 104,575,110 104,575,110   104,575,110        
Beginning balance at Dec. 31, 2023 $ 222,423,000   217,070,000 $ 1,000 $ 1,000 555,133,000 (338,065,000) 5,353,000
Common stock, Beginning balance (in shares) at Dec. 31, 2023 51,618,208       51,618,208      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance and exchange of equity (in shares)         16,498,104      
Issuance and exchange of equity $ 1,000   1,000   $ 1,000      
Issuance of preferred stock warrants 9,542,000   9,542,000     9,542,000    
Common stock repurchase and retirement (in shares)         (186,054)      
Common stock repurchase and retirement (1,001,000)   (1,001,000)     (1,001,000)    
Exercise of stock options and warrants (in shares)         1,370,026      
Exercise of stock options and warrants 3,037,000   3,037,000     3,037,000    
Stock compensation expense 38,726,000   38,726,000     38,726,000    
Noncontrolling interest investment in subsidiary 290,000             290,000
Dividends & redemptions of subsidiaries (1,332,000)   (1,265,000)     (1,265,000)   (67,000)
Issuance of Series E preferred stock, net of issuance costs (in shares)       7,325,385        
Issuance of Series E preferred stock, net of issuance costs 71,774,000   71,774,000 $ 1,000   71,773,000    
Net income (loss) $ 19,915,000   17,214,000       17,214,000 2,701,000
Preferred Stock, Ending balance (in shares) at Dec. 31, 2024 111,900,495 111,900,495   111,900,495        
Ending balance at Dec. 31, 2024 $ 363,375,000   355,098,000 $ 2,000 $ 2,000 675,945,000 (320,851,000) 8,277,000
Common stock, Ending balance (in shares) at Dec. 31, 2024 69,300,284       69,300,284      
Preferred Stock, Beginning balance (in shares) at Jun. 30, 2024       110,626,501        
Beginning balance at Jun. 30, 2024 $ 302,680,000   294,868,000 $ 2,000 $ 2,000 648,530,000 (353,666,000) 7,812,000
Common stock, Beginning balance (in shares) at Jun. 30, 2024         68,479,148      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of preferred stock warrants 2,572,000   2,572,000     2,572,000    
Exercise of stock options and warrants (in shares)         182,719      
Exercise of stock options and warrants 0              
Stock compensation expense 4,533,000   4,533,000     4,533,000    
Dividends & redemptions of subsidiaries (16,000)             (16,000)
Issuance of Series E preferred stock, net of issuance costs (in shares)       1,273,994        
Issuance of Series E preferred stock, net of issuance costs 12,376,000   12,376,000     12,376,000    
Net income (loss) 27,427,000   27,339,000       27,339,000 88,000
Preferred Stock, Ending balance (in shares) at Sep. 30, 2024       111,900,495        
Ending balance at Sep. 30, 2024 $ 349,572,000   341,688,000 $ 2,000 $ 2,000 668,011,000 (326,327,000) 7,884,000
Common stock, Ending balance (in shares) at Sep. 30, 2024         68,661,867      
Preferred Stock, Beginning balance (in shares) at Dec. 31, 2024 111,900,495 111,900,495   111,900,495        
Beginning balance at Dec. 31, 2024 $ 363,375,000   355,098,000 $ 2,000 $ 2,000 675,945,000 (320,851,000) 8,277,000
Common stock, Beginning balance (in shares) at Dec. 31, 2024 69,300,284       69,300,284      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of preferred stock warrants $ 7,863,000   7,863,000     7,863,000    
Exercise of stock options and warrants (in shares)       2,010,410 1,006,731      
Exercise of stock options and warrants 8,737,000   8,737,000 $ 1,000   8,736,000    
Stock compensation expense 22,730,000   22,730,000     22,730,000    
Noncontrolling interest investment in subsidiary 100,000             100,000
Dividends & redemptions of subsidiaries (146,000)             (146,000)
Net income (loss) $ 119,203,000   118,698,000       118,698,000 505,000
Preferred Stock, Ending balance (in shares) at Sep. 30, 2025 0 0   0        
Ending balance at Sep. 30, 2025 $ 1,176,560,000   1,167,824,000 $ 0 $ 0 1,369,956,000 (202,153,000) 8,736,000
Common stock, Ending balance (in shares) at Sep. 30, 2025         0      
Preferred Stock, Beginning balance (in shares) at Jun. 30, 2025       111,900,495        
Beginning balance at Jun. 30, 2025 404,460,000   395,930,000 $ 2,000 $ 2,000 687,655,000 (291,729,000) 8,530,000
Common stock, Beginning balance (in shares) at Jun. 30, 2025         69,939,160      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of preferred stock warrants 2,459,000   2,459,000     2,459,000    
Exercise of stock options and warrants (in shares)       2,010,410 367,855      
Exercise of stock options and warrants 7,692,000   7,692,000 $ 1,000   7,691,000    
Stock compensation expense 17,469,000   17,469,000     17,469,000    
Dividends & redemptions of subsidiaries (40,000)             (40,000)
Net income (loss) $ 89,822,000   89,576,000       89,576,000 246,000
Preferred Stock, Ending balance (in shares) at Sep. 30, 2025 0 0   0        
Ending balance at Sep. 30, 2025 $ 1,176,560,000   $ 1,167,824,000 $ 0 $ 0 $ 1,369,956,000 $ (202,153,000) $ 8,736,000
Common stock, Ending balance (in shares) at Sep. 30, 2025         0